4.7 Article

Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD)

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

Kenneth Marek et al.

NEUROLOGY (2014)

Article Clinical Neurology

Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients

Roberto Erro et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Clinical Neurology

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)

L. Silveira-Moriyama et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Clinical Neurology

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients

I. Trender-Gerhard et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging

Vicky L. Marshall et al.

NUCLEAR MEDICINE COMMUNICATIONS (2006)

Article Endocrinology & Metabolism

Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test

R Saunders-Pullman et al.

MOLECULAR GENETICS AND METABOLISM (2004)

Article Clinical Neurology

The phenylalanine loading test in the differential diagnosis of dystonia

O Bandmann et al.

NEUROLOGY (2003)

Article Clinical Neurology

Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)

M Segawa et al.

ANNALS OF NEUROLOGY (2003)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY